Skip to main content

AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Investor Securities Class Action Lawsuit 03/18/2010

  • If you purchased shares of AMAG Pharmaceuticals Inc, you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 30, 2015 - The court held a final settlement hearing and approved the settlement, entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice. October 2, 2014 - The court preliminarily approved the settlement. September 12, 2014 - Parties filed a stipulation of settlement. April 9, 2014 - The cou...



You must register (for free) or login to view the entire case.